Professor Preethi Kesavan, Director of Studies and Head, School of Advanced Technology and Digital Media at the London School of Business and Finance Singapore, analyses the Singaporean perspective on science and technology in advancing global healthcare.
As global air pollution levels increase, so has the toll it has taken on human health, as new data from the Air Quality Life Index (AQLI) reveals. However, this toll is not felt equally across the globe; why?
Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.
Tuberculosis is the second most infectious deadly disease after COVID-19, so why has it been met with political inertia? Vinny Wooding, Senior Parliamentary Advocacy Officer at RESULTS UK, discusses the burden of TB and the rapid action needed to address this global threat.
We spoke to Dr Joanne Hackett, Former Chief Commercial Officer of Genomics England and Regional Board Member of Movement Health 2030, about how genomic...
The Honourable Pascale St-Onge, Canada’s Minister responsible for Sport, shares her vision for a safe and accountable sport system in which Canadian athletes from all walks of life can thrive.
A&E departments across the UK are stretched, resulting in poor patient experiences and worse outcomes – but health technology could help streamline patient data.
The promise of connected care has expanded the opportunities for how clinicians and patients interact, offering care from a distance and creating a shift towards more accessible systems.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how tackling wasted medicines is crucial to achieving sustainable healthcare.
Greener surgery practices must be integrated into healthcare systems now. Reducing costs and increasing efficiencies will become possible with new energy-efficient operating theatre technology from Jones AV.
Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
